Long-Term Effects of Incentives for HIV Viral Suppression: A Randomized Clinical Trial
| dc.contributor.author | Novak, Matthew | |
| dc.contributor.author | Holtyn, August F. | |
| dc.contributor.author | Toegel, Forrest | |
| dc.contributor.author | Rodewald, Andrew M. | |
| dc.contributor.author | Leoutsakos, Jeannie-Marie | |
| dc.contributor.author | Fingerhood, Michael | |
| dc.contributor.author | Silverman, Kenneth | |
| dc.date.accessioned | 2024-05-06T15:05:55Z | |
| dc.date.available | 2024-05-06T15:05:55Z | |
| dc.date.issued | 2023-12-20 | |
| dc.description.abstract | Achieving viral suppression in people living with HIV improves their quality of life and can help end the HIV/AIDS epidemic. However, few interventions have successfully promoted HIV viral suppression. The purpose of this study was to evaluate the long-term effectiveness of financial incentives for viral suppression in people living with HIV. People living with a detectable HIV viral load (≥200 copies/mL) were randomly assigned to Usual Care (n=50) or Incentive (n=52) groups. Incentive participants earned up to $10 per day for providing blood samples with an undetectable or reduced viral load. During the 2-year intervention period, the percentage of blood samples with a suppressed viral load was significantly higher among Incentive participants (70%) than Usual Care participants (43%) (OR=7.1, 95% CI 2.7 to 18.8, p<.001). This effect did not maintain after incentives were discontinued. These findings suggest that frequent delivery of large-magnitude financial incentives for viral suppression can produce large and long-lasting improvements in viral load in people living with HIV. ClinicalTrials.gov Identifier: NCT02363387. | |
| dc.description.sponsorship | The work was supported by the National Institute of Allergy and Infectious Diseases and the National Institute on Drug Abuse of the National Institutes of Health under grants R01AI117065 and T32DA07209. The funders had no role in the study design, data collection, data analysis, data interpretation or writing of the report. | |
| dc.description.uri | https://link.springer.com/article/10.1007/s10461-023-04249-z | |
| dc.format.extent | 30 pages | |
| dc.genre | journal articles | |
| dc.genre | postprints | |
| dc.identifier | doi:10.13016/m2mjul-0vsn | |
| dc.identifier.citation | Novak, Matthew D., August F. Holtyn, Forrest Toegel, Andrew M. Rodewald, Jeannie-Marie Leoutsakos, Michael Fingerhood, and Kenneth Silverman. “Long-Term Effects of Incentives for HIV Viral Suppression: A Randomized Clinical Trial.” AIDS and Behavior 28, no. 2 (February 1, 2024): 625–35. https://doi.org/10.1007/s10461-023-04249-z. | |
| dc.identifier.uri | https://doi.org/10.1007/s10461-023-04249-z | |
| dc.identifier.uri | http://hdl.handle.net/11603/33611 | |
| dc.language.iso | en_US | |
| dc.publisher | Springer | |
| dc.relation.isAvailableAt | The University of Maryland, Baltimore County (UMBC) | |
| dc.relation.ispartof | UMBC Faculty Collection | |
| dc.relation.ispartof | UMBC Psychology Department | |
| dc.rights | Access to this item will begin on 12-20-2024. | |
| dc.subject | Contingency management | |
| dc.subject | HIV | |
| dc.subject | Incentives | |
| dc.subject | Medication adherence | |
| dc.subject | Viral suppression | |
| dc.title | Long-Term Effects of Incentives for HIV Viral Suppression: A Randomized Clinical Trial | |
| dc.type | Text | |
| dcterms.creator | https://orcid.org/0000-0002-2889-2819 |
